Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lisa Blumencranz"'
Autor:
Charles E. Cox, Shiyu Wang, Lisa Blumencranz, Amy Truitt, Andrea Menicucci, Steven C. Shivers, Mehran Habibi, Peter W. Blumencranz, William Audeh, Jolanta L. Baginski, Geza Acs
Publikováno v:
Cancer Research. 81:PS6-41
Background: Elderly breast cancer (BC) patients are an understudied population, with limited evidence regarding treatment options and outcomes and a lack of research involving prognostic multigene assays for this group. One study in patients 65-89 ye
Autor:
Dipali Sharma, William Audeh, Raquel Nunes, Sahra Uygun, Mehran Habibi, Lisa Blumencranz, Heather M. Kling, Jennifer A. Crozier, Sarah Untch
Publikováno v:
Cancer Research. 81:PS7-68
Background: African American breast cancer patients (AA) are diagnosed at a younger age and present more frequently with triple-negative/Basal tumors than Caucasian American patients (CA). High prevalence of obesity, type 2 diabetes mellitus (T2DM),
Autor:
Lisa Blumencranz, Raye Budway, Michaela Tsai, Robin Zon, Joseph McKelley, Rubina Qamar, Hatem Soliman, Sarah Untch, B Mavromatis, Shelly S. Lo, Pat Whitworth, William Audeh, Ellis G. Levine
Publikováno v:
Cancer Research. 80:P2-14
Background: The PROMIS trial (NCT01617954) previously evaluated how a definitive result from the MammaPrint 70-gene signature (70-GS) can impact treatment recommendations for patients with an intermediate range recurrence score (RS 18-30) from the 21
Autor:
Raquel Nunes, William Audeh, Sahra Uygun, Erin Yoder, Sarah Untch, Lisa Blumencranz, Heather M. Kling, Jennifer A. Crozier
Publikováno v:
Cancer Research. 80:P2-10
Background: Breast cancer (BC) mortality is higher in African-American women (AA) than in Caucasian women (CA). AA are also diagnosed at a younger age, have more aggressive subtypes and greater incidence of metabolic dysfunction such as obesity and d
Autor:
Erin Yoder, P Baron, Lisa Blumencranz, Thomas Lomis, Adam Brufsky, Gordan Srkalovic, Sarah Untch, Jennifer A. Crozier, Peter W. Blumencranz, P Whitworth, E Rehmus, William Audeh, B Mavromatis, LL Lee, Ian Grady
Publikováno v:
Cancer Research. 79:OT1-13
BACKGROUND: Genomic signatures are revolutionizing the definition, identification, and treatment of breast cancer subtypes. The ability of genomic signatures to enable fine grained stratification of breast cancers to the granular disease level is sti
Autor:
William Audeh, S Neijenhuis, A Høst-Ragab, VP Retèl, Mehran Habibi, Lisa Blumencranz, H Garlich, C Hwang
Publikováno v:
Cancer Research. 79:P5-15
Background: MINDACT provided evidence that MammaPrint (MP) can identify patients (pts) with early-stage breast cancer (ESBC) who can safely forego adjuvant chemotherapy (CT). As a result, 46% of clinicopathologically high-risk pts were spared from un
Publikováno v:
Cancer Research. 78:P6-13
This abstract was not presented at the symposium.
Publikováno v:
Cancer Research. 78:P2-09
Background: Cyclin-dependent kinase (CDK) 4/6 inhibitors are being evaluated in the adjuvant setting for patients with resected early stage hormone receptor positive (HR+) and HER2 negative (HER2-) breast cancer (BC). However, biomarkers that predict
Autor:
Vijayakrishna K. Gadi, Dipali Sharma, Oana Cristina Danciu, Yael Simons, Heather M. Kling, Sahra Uygun, Lisa Blumencranz, Mehran Habibi, Kent Hoskins, William Audeh, Jennifer A. Crozier
Publikováno v:
Journal of Clinical Oncology. 39:1009-1009
1009 Background: African American breast cancer patients (AA) are diagnosed younger, have more high-risk features, and poorer clinical outcomes than non-Hispanic White patients (NHW), despite similar treatments. Although comorbidities such as obesity
Autor:
Lisa Blumencranz, Patricia A. Robinson, Michaela L. Tsai, William Audeh, Heather M. Kling, Michelle L. Bolner, June Lee, Shelly S. Lo, Matei P. Socoteanu
Publikováno v:
Journal of Clinical Oncology. 39:e12568-e12568
e12568 Background: Genomic risk of recurrence assays provide prognostic information that aids treatment recommendations for patients with early breast cancer (EBC). The 70-gene signature (MammaPrint/MP) and the 21-gene assay (Oncotype DX/ODX) were bo